PET Imaging & Targeted Therapies in Cancer: A Masterclass Series
SESSION THREE: PET Imaging and Targeted Therapies in Hematological Malignancies
The “PET Imaging & Targeted Therapies in Cancer” Masterclass Series is a unique and comprehensive educational series organized by the Sweden Ghana Medical Centre (SGMC) in partnership with Continuous Education Services (CES). This training program is designed to enhance healthcare professionals’ expertise in the use of PET (Positron Emission Tomography) imaging and advanced targeted therapies across various types of cancer. Participants will gain a deeper understanding of PET imaging’s critical role in cancer diagnosis, treatment planning, and patient monitoring, as well as the latest advancements in targeted therapies.
The series consists of five specialized sessions, each focusing on a specific cancer type and addressing its unique challenges and innovations in care. Each session will be led by highly qualified and experienced facilitators in oncology and medical imaging, bringing together theoretical insights and practical applications in an interactive format. The series will incorporate Q&A sessions to encourage in-depth discussions and ensure that participants gain actionable knowledge to apply in clinical practice.
SESSION BREAKDOWN
Each individual topic in the series has been carefully crafted to build on the knowledge acquired in previous sessions while allowing participants to engage deeply with each aspect of PET imaging and targeted therapies in cancer. The topics include:
Session 1: The Significance of PET Scans in Oncology: A Cornerstone of Modern Cancer Care
Session 2: Enhancing Breast Cancer Management through PET Scans and Targeted Therapies
Session 3: PET Imaging and Targeted Therapies in Hematological Malignancies
Session 4: Lung Cancer Diagnosis and Treatment: The Impact of PET Imaging and Targeted Therapies
Session 5: Prostate Cancer Management: The Role of PET Imaging and Advanced Therapies
EARN CPD POINTS
Participants will earn valuable CPD points upon successful completion of each session, supporting their continuous professional development and helping them stay at the forefront of advancements in cancer care. This credentialing underscores the commitment of SGMC to foster professional growth and knowledge enhancement in the medical community, ensuring that participants are recognized for their dedication to advancing patient outcomes.
WHY REGISTER AND ATTEND THIS TRAINING SERIES?
This masterclass series offers a unique opportunity to learn from renowned experts and gain cutting-edge knowledge in the rapidly evolving field of cancer diagnostics and treatment. Whether you're an oncologist, radiologist, or healthcare professional interested in oncology, attending these sessions will provide you with practical insights and the latest research to elevate patient care. Participants will also benefit from an interactive format, engaging directly with facilitators and peers through thought-provoking discussions and Q&A sessions.
SESSION 3: PET Imaging and Targeted Therapies in Hematological Malignancies
This session focuses on the pivotal role of PET imaging in the diagnosis, staging, and treatment monitoring of hematological malignancies, including lymphoma and leukemia. Participants will gain insights into the integration of PET scans into clinical workflows, enhancing the accuracy of disease detection and therapeutic response evaluation. Additionally, the session explores advancements in targeted treatments for hematological cancers and how PET imaging aids in optimizing these therapies. Facilitated by leading experts, this interactive session is designed to empower participants with cutting-edge knowledge and practical strategies to enhance outcomes in hematological.
ORGANIZED BY
PROUDLY SPONSORED BY
This virtual training will premier on Thursday the 28th of November 2024 at 4:00 PM.
Target Audience: Medical Doctors, Pharmacists, Nurses and Radiotherapists
Moderator: Dr. Amankwaa Frempong
Date: Thursday 28th November 2024
Time: 16:00 GMT (4:00 pm local time)
AGENDA
Thursday 28th November 2024 (VIRTUAL EVENT)
The MASTERCLASS IN PET IMAGING & TARGETED THERAPIES FOR CANCER CARE begins with a foundational session, THE SIGNIFICANCE OF PET SCANS IN ONCOLOGY – A CORNERSTONE OF MODERN CANCER CARE. This session focuses on the pivotal role of PET imaging in the diagnosis, staging, and treatment monitoring of hematological malignancies, including lymphoma and leukemia. Participants will gain insights into the integration of PET scans into clinical workflows, enhancing the accuracy of disease detection and therapeutic response evaluation. Additionally, the session explores advancements in targeted treatments for hematological cancers and how PET imaging aids in optimizing these therapies. Facilitated by leading experts, this interactive session is designed to empower participants with cutting-edge knowledge and practical strategies to enhance outcomes in hematological
BSc, MBChB, MGCP, PhD Candidate
Specialist Haematologist | Acting Head-Clinical Haematology Unit- Laboratory Services Directorate
Komfo Anokye Teaching Hospital, Kumasi
Dr. Mrs. Eunice Agyeman Ahmed is a Specialist Haematologist at Komfo Anokye Teaching Hospital, Kumasi, where she also serves as the Acting Head of the Clinical Haematology Unit within the Laboratory Services Directorate.
View full profile / coursesMBBS, FWACP
Senior Lecturer, Director of the Haematology Department (Adult Sickle Cell Clinic), Head of Haematology at KBTH
Ghana Institute of Clinical Genetics, Korlrbu Teaching Hospital, Accra, Ghana.
Dr. Yvonne Dei-Adomakoh has over twenty-three (23) years of medical practice. She is currently a Consultant Haematologist at Korle-bu Teaching hospital and a Senior Lecturer at the Department of Haematology, University of Ghana Medical School.
View full profile / courses